Martin Shkreli Inu (@msitoken) 's Twitter Profile
Martin Shkreli Inu

@msitoken

Building something cool

ID: 1528115710228148225

linkhttp://www.msitoken.com calendar_today21-05-2022 20:49:32

103 Tweet

1,1K Followers

16 Following

Martin Shkreli Inu (@msitoken) 's Twitter Profile Photo

It's the weekend $MSI family! Get out there an enjoy yourselves! Or come party with us in the TG!🔥 t.me/martinshkrelii…

CoinCarp (@coincarpcom) 's Twitter Profile Photo

🚀Top 10 Crypto Gainers Today🚀 $HYFII +308.87%↑ $POPK +276.86%↑ $MSI +219.26%↑ $ORT +135.96%↑ $DRK +114.29%↑ $SCC +96.39%↑ $TSUKA +93.12%↑ $ORT +87.95%↑ #DOGEDIGGER +78.50%↑ $RIF +70.84%↑ More Info👇 coincarp.com/gainers-losers/

🚀Top 10 Crypto Gainers Today🚀

$HYFII  +308.87%↑
$POPK +276.86%↑
$MSI     +219.26%↑
$ORT    +135.96%↑
$DRK   +114.29%↑
$SCC  +96.39%↑
$TSUKA +93.12%↑
$ORT  +87.95%↑
#DOGEDIGGER +78.50%↑
$RIF   +70.84%↑

More Info👇
coincarp.com/gainers-losers/
Gokhshtein (@gokhshtein) 's Twitter Profile Photo

NEWS UPDATE: "Pharma Bro" Martin Shkreli joins the #Web3 world launching @druglike_io, a free-to-use "decentralized computing network...for anyone looking to start or contribute to early-stage drug discovery projects." 💊 #CryptoNews #Druglike #Medicine #Pharmaceuticals

unusual_whales (@unusual_whales) 's Twitter Profile Photo

Martin Shkreli, known as the Pharma Bro and who was banned from the pharmaceutical industry, has created a cryptocurrency computational chemistry platform for drug discovery called Druglike, with the ERC-20 token $MSI.

WIRED (@wired) 's Twitter Profile Photo

The ex-pharmaceutical executive fresh from prison announced his latest, eyebrow-raising venture this week: the creation of a blockchain-based Web3 drug discovery platform that traffics in his own cryptocurrency, MSI, aka Martin Shkreli Inu. wired.trib.al/7qBiITS

Martin Shkreli Inu (@msitoken) 's Twitter Profile Photo

Computer aided drug discovery helped bring to market HIV-1-inhibiting drugs atazanavir, saquinavir, indinavir, and ritonavir Welcome to the future Druglike